These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 24832618)

  • 1. Bacterial vaginosis and the cervicovaginal immune response.
    Mitchell C; Marrazzo J
    Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.
    Murphy K; Mitchell CM
    J Infect Dis; 2016 Aug; 214 Suppl 1(Suppl 1):S29-35. PubMed ID: 27056955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicovaginal cytokines, sialidase activity and bacterial load in reproductive-aged women with intermediate vaginal flora.
    Santos-Greatti MMV; da Silva MG; Ferreira CST; Marconi C
    J Reprod Immunol; 2016 Nov; 118():36-41. PubMed ID: 27620141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study.
    Alcaide ML; Strbo N; Romero L; Jones DL; Rodriguez VJ; Arheart K; Martinez O; Bolivar H; Podack ER; Fischl MA
    PLoS One; 2016; 11(4):e0153045. PubMed ID: 27078021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
    PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
    Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
    PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
    McKinnon LR; Achilles SL; Bradshaw CS; Burgener A; Crucitti T; Fredricks DN; Jaspan HB; Kaul R; Kaushic C; Klatt N; Kwon DS; Marrazzo JM; Masson L; McClelland RS; Ravel J; van de Wijgert JHHM; Vodstrcil LA; Tachedjian G
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):219-228. PubMed ID: 30638028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis.
    Hemalatha R; Ramalaxmi BA; KrishnaSwetha G; Kumar PU; Rao DM; Balakrishna N; Annapurna V
    Am J Med Sci; 2012 Jul; 344(1):35-9. PubMed ID: 22157388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
    Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
    J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis.
    Mitchell C; Fredricks D; Agnew K; Hitti J
    Sex Transm Dis; 2015 Jul; 42(7):358-63. PubMed ID: 26222747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
    Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
    Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.